R. K ppers and colleagues made the seminal observation that blood B cells in humans were very different from mice s one because centers (GC) that prevents hypermutation and isotype switch , one can detect a clear IgM-only CD27 B cell subset in blood, suggesting
[4] + that these cells could be GC precursors of switched cells that would now accumulate and thus appear in the circulation .
[2]
Asking the question of the origin of IgM IgD CD27 B cells, it was observed that hyper-IgM patients who lack either a functional 
No marginal zone (MZ) B cell lineage in humans?
It has been shown thereafter that blood and splenic IgM IgD CD27 B cells, which represent 10 to 30 of total B cells in normal . The marginal zone B cell sub-population was originally described as a separate lineage in rodents, bearing the CD21 CD23 IgM IgD AID-positive cells in the human spleen , since the expression of AID is an absolute requisite for the occurrence of Ig gene [11] hypermutation , . They found the frequency of AID-positive cells to be very low in the splenic marginal zone, and thus favor the [4 12] proposition that most marginal zone B cells are in fact derived in humans from a T-dependent response taking place in germinal centers.
One should emphasize that the obvious conclusion of this proposition is that, as opposed to rodents, a distinct marginal zone B cell sub-population does not exist as such in humans. Taking into account the clear anatomical differences between rodent and human spleen, it would suggest that, instead of being a separate B cell lineage, marginal zone B cells arise in humans as a branching point during germinal center differentiation, after some accumulation of somatic mutation but before the onset of isotype switch ( ). We obviously do not fig. 1 favor this interpretation and think, along with others, that, although the splenic marginal zone is a complex lymphoid niche, humans have evolved like rodents a separate sub-population of B cells which reside in this splenic compartment, are pre-activated and respond rapidly to blood-born TI antigens , , .
[7 13 14] Other sites for diversification of IgM IgD CD27 B cells?
Hypermutation being the hallmark of a T-dependent germinal center reaction, the confusion arise from the fact that marginal zone B cells in humans carry a mutated Ig receptor and that vaccination against polysaccharidic antigens raise mutated antibodies . However [15] evolution has taught us that hypermutation and gene conversion can be used in several species in a T-independent and external antigen-free mode in order to generate a B cell pre-immune repertoire , . Moreover these molecular mechanisms that introduce [16 17 ] diversity in the three VH/VL complementarity-determining regions (CDRs) can provide these animals with a diversified antibody repertoire with all range of affinities against proteic and polysaccharidic determinants present at the surface of pathogens.
Strikingly in humans this circulating and splenic marginal zone B cell population is already well expanded and mutated at a stage at which T-independent responses against encapsulated bacteria cannot take place (before 2 years), which led us to suggest that these cells could in fact mutate their IgM receptor la sheep while they are generated, before responding to external antigens . The place where hypermutation taking place in marginal zone B cells after a T-independent challenge may only concern a very small number of cells, or that they would emigrate rapidly after stimulation, or even possibly, that the intra-clonal diversification observed represent independent activation of clonally related cells and not reactivation of the hypermutation process during the T-independent immune response.
How much AID does it take to perform hypermutation?
A last point of discussion concerns the sensitivity of AID detection assay. The IgM IgD CD27 shows an Ig gene mutation frequency
significantly lower than switched B cells (by a factor of 2, approximately ). Moreover, the actual accumulation of mutation could be a thus arguing against a trivial contamination in the purification procedure (our unpublished data). As AID is also required to induce class switching, these data raise only the question of the sensitivity of the in situ detection, but cannot lead to the formal conclusion that hypermutation is occurring in marginal zone B cells.
In conclusion, if one assumes that, in spite of the lack of detection of AID expression in the splenic marginal zone reported here by . Marginal zone B cells in humans [10] have been proposed to undergo diversification of their Ig genes outside of an immune response . An alternate proposition (marked by the [2] dotted arrow) is that splenic marginal zone B cells in humans are a subset arising during germinal center differentiation, after the onset of somatic mutation and before isotype switch .
